Oncology Institute, Inc. Quarterly Operating Income (Loss) in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oncology Institute, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q4 2019 to Q3 2024.
  • Oncology Institute, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$13.9M, a 0.52% increase year-over-year.
  • Oncology Institute, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$63.5M, a 26.9% increase year-over-year.
  • Oncology Institute, Inc. annual Operating Income (Loss) for 2023 was -$77M, a 6.02% increase from 2022.
  • Oncology Institute, Inc. annual Operating Income (Loss) for 2022 was -$82M, a 78.7% decline from 2021.
  • Oncology Institute, Inc. annual Operating Income (Loss) for 2021 was -$45.9M, a 459% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$63.5M -$13.9M +$72K +0.52% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$63.5M -$16.4M -$1.43M -9.55% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$62.1M -$18M +$14.9M +45.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$77M -$15.3M +$9.79M +39% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$86.8M -$13.9M +$6.17M +30.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$93M -$14.9M +$3.37M +18.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$96.3M -$32.9M -$14.4M -77.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$82M -$25.1M +$15.8M +38.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$97.7M -$20.1M -$17.9M -832% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$79.8M -$18.3M -$17.2M -1540% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$62.6M -$18.5M -$16.7M -954% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$45.9M -$40.8M -$33.1M -429% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$12.7M -$2.16M -$1.96M -987% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$10.8M -$1.12M -$921K -474% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$9.86M -$1.75M -$1.67M -1897% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$8.2M -$7.72M -$7.71M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$483K -$198K Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-14
Q2 2020 -$195K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$87.8K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-28
Q4 2019 -$2.3K* Nov 1, 2019 Dec 31, 2019 10-K/A 2021-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.